Transversus Abdominis Plane Block From Abdominal Approach

June 29, 2010 updated by: United Christian Hospital

Transversus Abdominis Plane Block From Intraabdominal Approach in Patients Undergoing Total Abdominal Hysterectomy: a Randomized Controlled Trial

Randomized double blind placebo controlled trial on transversus abdominus plane block approached from abdominal cavity, in patients undergoing total abdominal hysterectomy.

Study Overview

Detailed Description

Potential advantages compared to percutaneous approach are decrease in risk of visceral injury as it is under direct visual and tactile guidance, ease of approach in obese patients, short theatre time for administration, easy to administer.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kowloon
      • Kwun Tong, Kowloon, Hong Kong
        • Recruiting
        • Department Of Anaesthesiology, Pain medicine and Operating Services. United Christian Hospital
        • Contact:
          • Wing Yee Lillian Choy, MBBS (HK)
          • Phone Number: 3513 4245
        • Principal Investigator:
          • Wing Yee Lillian Choy, MBBS (HK)
        • Sub-Investigator:
          • Huey Sing Lim, FANZCA,FHKCA
        • Sub-Investigator:
          • Man Shun Law, FHKCA,FHKAM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • ASA physical status I-III
  • Age 18 or above
  • Scheduled to undergo TAH+/- salpingoophorectomy.
  • Scheduled to receive general anaesthesia under standardized anaesthetic regime.
  • Comprehends how to use intravenous patient controlled analgesia (IV PCA).
  • Is willing to complete the postoperative assessment.
  • Understands the nature and purpose of this study and the study procedures and has signed the informed consent form for this study to indicate this understanding.

Exclusion Criteria:

  • Known allergy to drugs involved in this study
  • Previously taking medications thought to result in opioid tolerance, or analgesics thought to interfere with subsequent opioid requirement.
  • Undergoing any procedures in addition to TAH+/- salpingoophorectomy.
  • With co-existing pathology resulting in persistent pain requiring analgesics.
  • Wound incision extending to supra-umbilical level.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 0.5% Ropivacaine
group receiving TAP block (0.5% ropivacaine at TAP plane)

This intraabdominal approach to TAP block is being used regularly by gynaecological surgeons in this hospital now.

To be performed bilaterally before surgical wound closure by an experienced surgeon who initially undergo initial observation by investigator to ensure uniformity in technique.

Local anaesthetic or placebo solution will be injected to TAP with blunt needle from within abdominal cavity under visual and tactile guidance at the triangle of Petit, after feeling one 'pop' through the transversus abdominis muscle to the TAP layer.

After careful aspiration to exclude vascular puncture, 1.5mg/kg of 0.5% ropivacaine or 0.3ml/kg of 0.9% saline placebo will be injected to each side slowly while observing for signs of toxicity.

Other Names:
  • TAP block
Placebo Comparator: normal saline
group receiving placebo (saline) at TAP plane

This intraabdominal approach to TAP block is being used regularly by gynaecological surgeons in this hospital now.

To be performed bilaterally before surgical wound closure by an experienced surgeon who initially undergo initial observation by investigator to ensure uniformity in technique.

Local anaesthetic or placebo solution will be injected to TAP with blunt needle from within abdominal cavity under visual and tactile guidance at the triangle of Petit, after feeling one 'pop' through the transversus abdominis muscle to the TAP layer.

After careful aspiration to exclude vascular puncture, 1.5mg/kg of 0.5% ropivacaine or 0.3ml/kg of 0.9% saline placebo will be injected to each side slowly while observing for signs of toxicity.

Other Names:
  • TAP block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative 24hr morphine consumption
Time Frame: 24 hours
The primary objective of this study is to demonstrate the effectiveness of tranversus abdominis plane block using the intraabdominal approach in reducing postoperative 24 hours morphine consumption after total abdominal hysterectomy (TAH) where time 0 is taken as time of arrival at PACU.
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
morphine consumption on arrival to post-anaesthetic care unit(PACU) and 4, 12 and 24 hours after.
Time Frame: 24hrs
• Assess and compare the morphine consumption on arrival to post-anaesthetic care unit(PACU) and 4, 12 and 24 hours after.
24hrs
Degree on pain according to numerical pain score on arrival to post-anaesthetic care unit(PACU) and 4, 12 and 24 hours after during rest and movement (cough
Time Frame: 24hrs
24hrs
incidence of nausea and vomiting
Time Frame: 24hours postoperatively
24hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wing Yee Lillian Choy, MBBS (HK), United Christian Hospital, Hospital Authority

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Anticipated)

October 1, 2010

Study Completion (Anticipated)

October 1, 2010

Study Registration Dates

First Submitted

June 14, 2010

First Submitted That Met QC Criteria

June 14, 2010

First Posted (Estimate)

June 15, 2010

Study Record Updates

Last Update Posted (Estimate)

June 30, 2010

Last Update Submitted That Met QC Criteria

June 29, 2010

Last Verified

June 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • Protocol ver 1.1
  • KC/KE-10-0021/FR-3 (Other Identifier: Research Ethics committee (Kowloon Central/Kowloon East))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transversus Abdominis Plane Block From Abdominal Approach

Clinical Trials on Transversus abdominis plane block

3
Subscribe